Show simple item record

dc.contributor.authorLoveday, C
dc.contributor.authorLitchfield, K
dc.contributor.authorProszek, PZ
dc.contributor.authorCornish, AJ
dc.contributor.authorSanto, F
dc.contributor.authorLevy, M
dc.contributor.authorMacintyre, G
dc.contributor.authorHolryod, A
dc.contributor.authorBroderick, P
dc.contributor.authorDudakia, D
dc.contributor.authorBenton, B
dc.contributor.authorBakir, MA
dc.contributor.authorHiley, C
dc.contributor.authorGrist, E
dc.contributor.authorSwanton, C
dc.contributor.authorHuddart, R
dc.contributor.authorPowles, T
dc.contributor.authorChowdhury, S
dc.contributor.authorShipley, J
dc.contributor.authorO'Connor, S
dc.contributor.authorBrenton, JD
dc.contributor.authorReid, A
dc.contributor.authorde Castro, DG
dc.contributor.authorHoulston, RS
dc.contributor.authorTurnbull, C
dc.date.accessioned2020-05-18T14:15:34Z
dc.date.issued2020-05-04
dc.identifier.citationNature communications, 2020, 11 (1), pp. 2189 - ?
dc.identifier.issn2041-1723
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/3613
dc.identifier.eissn2041-1723
dc.identifier.doi10.1038/s41467-020-15768-x
dc.description.abstractWhile most testicular germ cell tumours (TGCTs) exhibit exquisite sensitivity to platinum chemotherapy, ~10% are platinum resistant. To gain insight into the underlying mechanisms, we undertake whole exome sequencing and copy number analysis in 40 tumours from 26 cases with platinum-resistant TGCT, and combine this with published genomic data on an additional 624 TGCTs. We integrate analyses for driver mutations, mutational burden, global, arm-level and focal copy number (CN) events, and SNV and CN signatures. Albeit preliminary and observational in nature, these analyses provide support for a possible mechanistic link between early driver mutations in RAS and KIT and the widespread copy number events by which TGCT is characterised.
dc.formatElectronic
dc.format.extent2189 - ?
dc.languageeng
dc.language.isoeng
dc.publisherNATURE PUBLISHING GROUP
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectHumans
dc.subjectNeoplasms, Germ Cell and Embryonal
dc.subjectTesticular Neoplasms
dc.subjectGenetic Predisposition to Disease
dc.subjectPlatinum
dc.subjectOrganoplatinum Compounds
dc.subjectras Proteins
dc.subjectGenomics
dc.subjectSignal Transduction
dc.subjectDrug Resistance, Neoplasm
dc.subjectMutation
dc.subjectMale
dc.subjectProto-Oncogene Proteins c-kit
dc.subjectDNA Copy Number Variations
dc.subjectWhole Exome Sequencing
dc.titleGenomic landscape of platinum resistant and sensitive testicular cancers.
dc.typeJournal Article
dcterms.dateAccepted2020-03-23
rioxxterms.versionofrecord10.1038/s41467-020-15768-x
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2020-05-04
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfNature communications
pubs.issue1
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Sarcoma Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Cancer Genomics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Sarcoma Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Clinical Academic Radiotherapy (Huddart)
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Sarcoma Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Cancer Genomics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Sarcoma Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Clinical Academic Radiotherapy (Huddart)
pubs.publication-statusPublished
pubs.volume11
pubs.embargo.termsNot known
icr.researchteamCancer Genomics
icr.researchteamSarcoma Molecular Pathology
icr.researchteamClinical Academic Radiotherapy (Huddart)
dc.contributor.icrauthorLitchfield, Kevin
dc.contributor.icrauthorCornish, Alexander
dc.contributor.icrauthorBroderick, Peter
dc.contributor.icrauthorHuddart, Robert
dc.contributor.icrauthorShipley, Janet
dc.contributor.icrauthorHoulston, Richard
dc.contributor.icrauthorTurnbull, Clare


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0